
Rossari Biotech's Subsidiaries Unitop Chemicals and Tristar Intermediates Approve Capacity Expansion
Rossari Biotech Ltd. announced that the Board of Directors of its two material subsidiaries, Unitop Chemicals Private Limited and Tristar Intermediates Private Limited, have approved capacity expansion. The expansion is intended to accommodate new product lines, align with market demand forecasts, and enhance competitive edge in domestic and export markets. Unitop Chemicals Private Limited is set to add 18500 MTPA capacity, while Tristar Intermediates Private Limited will add 3600 MTPA. The total investment required is Rs. 97 Crores, to be financed through a mix of internal accruals and debt. The proposed capacity is expected to be added in a phased manner till the 4th quarter of FY 2025-26 for Unitop Chemicals and is expected to be commissioned by Q4 FY 2025-26 for Tristar Intermediates.
Key Highlights
- Rossari Biotech's subsidiaries Unitop Chemicals and Tristar Intermediates approve capacity expansion
- Unitop Chemicals to add 18500 MTPA capacity, Tristar Intermediates to add 3600 MTPA
- Total investment required is Rs. 97 Crores
- Expansion intended to accommodate new product lines and enhance competitive edge
- Capacity to be added in phased manner till 4th quarter of FY 2025-26 for Unitop Chemicals and is expected to be commissioned by Q4 FY 2025-26 for Tristar Intermediates